Accel Wealth Management’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $478K | Buy |
4,446
+4
| +0.1% | +$430 | 0.16% | 142 |
|
|
2025
Q1 | $448K | Sell |
4,442
-69
| -2% | -$6.96K | 0.16% | 135 |
|
|
2024
Q4 | $403K | Sell |
4,511
-12
| -0.3% | -$1.07K | 0.15% | 150 |
|
|
2024
Q3 | $379K | Sell |
4,523
-342
| -7% | -$28.7K | 0.14% | 158 |
|
|
2024
Q2 | $375K | Buy |
4,865
+1,680
| +53% | +$129K | 0.15% | 144 |
|
|
2024
Q1 | $218K | Buy |
+3,185
| New | +$218K | 0.09% | 202 |
|
|
2023
Q2 | – | Sell |
-950
| Closed | -$47.5K | – | 252 |
|
|
2023
Q1 | $47.5K | Sell |
950
-200
| -17% | -$10K | 0.02% | 500 |
|
|
2022
Q4 | $53.2K | Hold |
1,150
| – | – | 0.03% | 351 |
|
|
2022
Q3 | $47K | Hold |
1,150
| – | – | 0.03% | 382 |
|
|
2022
Q2 | $43K | Hold |
1,150
| – | – | 0.02% | 379 |
|
|
2022
Q1 | $52K | Sell |
1,150
-300
| -21% | -$13.6K | 0.03% | 370 |
|
|
2021
Q4 | $62K | Sell |
1,450
-200
| -12% | -$8.55K | 0.03% | 339 |
|
|
2021
Q3 | $72K | Sell |
1,650
-100
| -6% | -$4.36K | 0.05% | 269 |
|
|
2021
Q2 | $75K | Sell |
1,750
-550
| -24% | -$23.6K | 0.05% | 271 |
|
|
2021
Q1 | $89K | Sell |
2,300
-3,175
| -58% | -$123K | 0.07% | 231 |
|
|
2020
Q4 | $197K | Buy |
+5,475
| New | +$197K | 0.18% | 122 |
|